These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2461019)

  • 1. Biochemical characterization of scleroderma-inducing glycosaminoglycan.
    Ishikawa H; Kitabatake M; Akiyama F
    Acta Derm Venereol; 1988; 68(5):378-84. PubMed ID: 2461019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroderma-inducing glycosaminoglycan in the urine of patients with systemic scleroderma.
    Ishikawa H; Saito Y; Yamakage A; Kitabatake M
    Dermatologica; 1978; 156(4):193-204. PubMed ID: 564296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma.
    Ishikawa H; Suzuki S; Horiuchi R; Sato H
    Acta Derm Venereol; 1975; 55(2):97-107. PubMed ID: 48324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of sclerosis-inducing glycosaminoglycan in the skin of an amine-induced experimental skin sclerosis.
    Ishikawa H; Yamakage A; Kitabatake M; Katayama H; Saito Y
    Dermatologica; 1980; 161(3):145-51. PubMed ID: 7398992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to demonstrate fibrotic changes in the skin of mice injected with glycosaminoglycan fractions from the urine of scleroderma patients.
    Fox PK; White DD; Cavanagh M; Davies MG; Wusterman F
    Dermatologica; 1982 Feb; 164(2):90-4. PubMed ID: 7075853
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte responsiveness to urinary glycosaminoglycan in systemic scleroderma.
    Ishikawa H; Hattori A
    Dermatologica; 1979; 158(5):328-33. PubMed ID: 312217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Composition and degree of sulfation of glycosaminoglycans from tissues of different animal species: heterogeneity and tissue specificity of heparan sulfates].
    Zimina NP; Dmitriev IP; Rykova VI
    Biokhimiia; 1987 Jun; 52(6):984-90. PubMed ID: 2959327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma.
    Ozgen M; Koca SS; Isik A; Ozercan IH
    J Rheumatol; 2010 Mar; 37(3):678-9. PubMed ID: 20197571
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
    Erickson DR; Ordille S; Martin A; Bhavanandan VP
    J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of low sulfate concentrations on the glycosaminoglycan synthesis in anatomically intact articular cartilage of the mouse.
    van der Kraan PM; de Vries BJ; Vitters EL; van den Berg WB; van de Putte LB
    J Orthop Res; 1989; 7(5):645-53. PubMed ID: 2503596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycan content in the lung of the tight-skin mouse.
    Rosenberg GT; Ross SC; Osborn TG
    J Rheumatol; 1984 Jun; 11(3):318-20. PubMed ID: 6429328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological distinction between progressive and circumscript scleroderma].
    Ishikawa H; Mori S
    Hautarzt; 1972 Sep; 23(9):404-9. PubMed ID: 4264853
    [No Abstract]   [Full Text] [Related]  

  • 15. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
    Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
    Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silicone does not potentiate development of the scleroderma-like syndrome in tight skin (TSK/+) mice.
    Frondoza C; Jones L; Rose NR; Hatakeyama A; Phelps R; Bona C
    J Autoimmun; 1996 Aug; 9(4):473-83. PubMed ID: 8864822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis.
    Salmon-Ehr V; Serpier H; Nawrocki B; Gillery P; Clavel C; Kalis B; Birembaut P; Maquart FX
    Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride.
    Christner PJ; Artlett CM; Conway RF; Jiménez SA
    Arthritis Rheum; 2000 Nov; 43(11):2598-605. PubMed ID: 11083286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary glycosaminoglycans in systemic scleroderma].
    Astakhova TA; Balabanova RM
    Ter Arkh; 1980; 52(12):100-5. PubMed ID: 7245055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.